Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932

PURPOSE: AALL0932 evaluated two randomized maintenance interventions to optimize disease-free survival (DFS) while reducing the burden of therapy in children with newly diagnosed NCI standard-risk (SR) B-acute lymphoblastic leukemia (B-ALL). METHODS: AALL0932 enrolled 9,229 patients with B-ALL; 2,36...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Angiolillo, Anne L., Schore, Reuven J., Kairalla, John A., Devidas, Meenakshi, Rabin, Karen R., Zweidler-McKay, Patrick, Borowitz, Michael J., Wood, Brent, Carroll, Andrew J., Heerema, Nyla A., Relling, Mary V., Hitzler, Johann, Lane, Ashley R., Maloney, Kelly W., Wang, Cindy, Bassal, Mylène, Carroll, William L., Winick, Naomi J., Raetz, Elizabeth A., Loh, Mignon L., Hunger, Stephen P.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274746/
https://ncbi.nlm.nih.gov/pubmed/33411585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados